Hjem › Akut bifænotypisk leukæmi › Californien › Long Beach
Akut bifænotypisk leukæmi kliniske forsøg i Long Beach, CA
3 studier for Akut bifænotypisk leukæmi søger deltagere på steder i og omkring Long Beach (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
RekruttererFase 2
- Miller Children's and Women's Hospital Long Beach, Long Beach
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
RekruttererFase 3
- Miller Children's and Women's Hospital Long Beach, Long Beach
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RekruttererFase 1/2
- Miller Children's and Women's Hospital Long Beach, Long Beach
Akut bifænotypisk leukæmi forsøg i andre byer
- Seattle, WA15 studier
- Houston, TX11 studier
- New York City, NY10 studier
- Atlanta, GA9 studier
- Durham, NC8 studier
- Memphis, TN7 studier
- Chicago, IL7 studier
- Charlotte, NC6 studier
- Aurora, CO6 studier
- Baldwin Park, CA6 studier
- Portland, OR6 studier
- Los Angeles, CA6 studier
Andre studier i Long Beach
- Ikke-småcellet lungecancer12 studier
- Type 2-diabetes11 studier
- Lungecancer9 studier
- Brystkræft9 studier
- Alzheimers sygdom8 studier
- Prostatakræft7 studier
- Kræft (alle typer)6 studier
- Kardiovaskulær sygdom6 studier
- Overvægt5 studier
- Overvægt5 studier
- Demens5 studier
- Steatotisk leversygdom4 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.